NCT07052461 Association of Microcirculation, Vexus Score and Femoral Vein Doppler in Patients on the ICU After Non-emergency Cardiac Surgery
| NCT ID | NCT07052461 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Basel, Switzerland |
| Condition | Microcirculatory Diffusion |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-04-14 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2026-04-14 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the VeMic study is to explore if venous congestion is linked with microcirculatory impairment in elective cardiac surgery patients in the postoperative ICU stay.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years * Elective or urgent (need for definitive procedure during hospitalisation, but not emergency intervention) cardiac surgery Exclusion Criteria: * Age \< 18 years * Pregnant women * Known severe chronic kidney disease (estimated glomerular filtration rate \<15 mL/min per 1.73 m2 or dialysis) * Renal or liver transplantation * Any known condition interfering with Doppler evaluation of the portal system (including known or suspected cirrhosis or portal vein thrombosis or huge abdominal emphysema). * Inability to consent to study * Emergency cardiac surgery
Contact & Investigator
Martin Siegemund, Prof. MD
STUDY CHAIR
University Hospital of Basel
Frequently Asked Questions
Who can join the NCT07052461 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Microcirculatory Diffusion. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07052461 currently recruiting?
Yes, NCT07052461 is actively recruiting participants. Contact the research team at gregormichael.loosen@usb.ch for enrollment information.
Where is the NCT07052461 trial being conducted?
This trial is being conducted at Basel, Switzerland.
Who is sponsoring the NCT07052461 clinical trial?
NCT07052461 is sponsored by University Hospital, Basel, Switzerland. The principal investigator is Martin Siegemund, Prof. MD at University Hospital of Basel. The trial plans to enroll 40 participants.